Back
Pharming Group Quote, Financials, Valuation and Earnings
Sponsored
PHAR
Sponsored
The truth about AI stocks (must see)
Learn the names of all 10 stocks here. FREE.
Sell
42
PHAR
Pharming Group
Last Price:
8.12
Seasonality Move:
16.96%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.Pharming Group Price Quote
$8.12
-0.84 (-9.38%)
(Updated: October 24, 2024 at 6:55 PM ET)
Pharming Group Key Stats
Sell
42
Pharming Group (PHAR)
is a Sell
Day range:
$8.60 - $9.56
52-week range:
$6.65 - $13.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.54
P/B ratio:
2.74%
Volume:
14.2K
Avg. volume:
7K
1-year change:
-12.11%
Market cap:
$606.2M
Revenue:
$245.3M
EPS:
$-0.19
How Much Does Pharming Group Make?
-
How Much Are Pharming Group's Sales Annually?
PHAR Revenues are $245.3M -
How Much Profit Does Pharming Group's Make A Year?
PHAR net income is -$10.5M
Is Pharming Group Growing As A Company?
-
What Is Pharming Group's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.35% -
What Is Pharming Group's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Pharming Group Stock Price Performance
-
Did Pharming Group Stock Go Up Last Month?
Pharming Group share price went up by 17% last month -
Did PHAR's Share Price Rise Over The Last Year?
PHAR share price fell by -12.11% over the past 1 year
What Is Pharming Group 52-Week High & Low?
-
What Is Pharming Group’s 52-Week High Share Price?
Pharming Group has traded as high as $13.20 over the past 52 weeks -
What Is Pharming Group’s 52-Week Low Share Price?
Pharming Group has traded as low as $6.65 over the past 52 weeks
Pharming Group Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Pharming Group?
-
How Much Debt Does Pharming Group Have?
Total long term debt quarterly is $90.5M -
How Much Cash Does Pharming Group Have?
Cash and short term investments quarterly total is $160.3M -
What Is Pharming Group’s Book Value Per Share?
Book value per share is 3.26
Is Pharming Group Cash Flow Positive?
-
What Is PHAR Cash Flow From Operations?
Cash flow from operations (TTM) is -$5.8M -
What Is Pharming Group’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$26.6M -
What Is Pharming Group’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$25.1M
Pharming Group Return On Invested Capital
-
Is Management Doing A Good Job?
PHAR return on invested capital is -3.95% -
What Is Pharming Group Return On Assets?
ROA measures how assets are converting to revenues and is -3.05% -
What Is PHAR Return On Equity?
ROE is a measure of profitability and is -6.31%
Pharming Group Earnings Date & Stock Price
-
What Is Pharming Group's Stock Price Today?
A single share of PHAR can be purchased today for 8.96 -
What Is Pharming Group’s Stock Symbol?
Pharming Group trades on the nasdaq under the ticker symbol: PHAR -
When Is Pharming Group’s Next Earnings Date?
The next quarterly earnings date for Pharming Group is scheduled on October 24, 2024 -
When Is PHAR's next ex-dividend date?
Pharming Group's next ex-dividend date is October 25, 2024 -
How To Buy Pharming Group Stock?
You can buy Pharming Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Pharming Group Competitors
-
Who Are Pharming Group's Competitors?
Below is a list of companies who compete with Pharming Group or are related in some way:
Pharming Group Dividend Yield
-
What Is PHAR Dividend Yield?
Pharming Group’s dividend yield currently is 0% -
What Is Pharming Group’s Payout Ratio?
Pharming Group’s payout ratio is 0% -
When Did Pharming Group Last Pay A Dividend?
The latest dividend pay date is October 25, 2024 -
What Is Pharming Group’s Dividend Per Share?
Pharming Group pays a dividend of $0.00 per share
Pharming Group Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 50% |
Revenue: | 34.97% | 2.91% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 34.00 |
Upside from Last Price: | 279.46% |